Global Animal Healthcare Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Global Animal Healthcare Market Segmentation, By Animal Type (Production Animal and Companion Animal), Product Type (Pharmaceuticals, Medical Devices, Veterinary Services, and Others), Distribution Channel (Retail, E-commerce, Hospital Pharmacy, and Others), End Use (Reference Laboratories, Point-of-care Testing/ In-house Testing, Veterinary Hospitals and Clinics, and Others) - Industry Trends and Forecast to 2033

What is the Global Animal Healthcare Market Size and Growth Rate?

• The global animal healthcare market size was valued at USD 174.88 billion in 2025 and is expected to reach USD 241.19 billion by 2033, at a CAGR of4.70% during the forecast period
• Growing presence of e-commerce platforms promoting online pharmacies will emerge as the major factor fostering the growth of market. Rise in the prevalence of zoonotic diseases in animals and increasing focus towards the adoption of practices that promote good health in animals are other factors fostering the growth of market

What are the Major Takeaways of Animal Healthcare Market?

• Growth in the expenditure for research and development proficiencies in regards to new product launches coupled with increasing personal disposable income will further create lucrative and remunerative growth opportunities for the market
• Rising demand for protein foods for animals, surging globalization and expansion in the number of livestock will also carve the way for the growth of the market
• North America dominated the animal healthcare market with a 32.25% revenue share in 2025, driven by high pet ownership rates, advanced veterinary infrastructure, and strong spending on companion animal care across the U.S. and Canada
• Asia-Pacific is projected to register the fastest CAGR of around 8.69% from 2026 to 2033, driven by rapid growth in livestock production, rising pet adoption, and increasing awareness of animal health across China, India, Japan, South Korea, and Southeast Asia
• The production animal segment dominated the market in 2025, accounting for around 55.6% of the total revenue share, driven by large-scale demand from livestock farming, poultry, dairy, and aquaculture industries

Report Scope and Animal Healthcare Market Segmentation 

What is the Key Trend in the Animal Healthcare Market?

Increasing Shift Toward Preventive Care, Digital Diagnostics, and Companion Animal Health

• The animal healthcare market is witnessing a strong shift toward preventive care, early disease detection, and advanced diagnostics, driven by rising pet ownership and increasing awareness of animal health and welfare
• Veterinary service providers and pharmaceutical companies are increasingly adopting digital diagnostic tools, point-of-care testing, and tele-veterinary platforms to enable faster diagnosis and improved treatment outcomes
• Growing demand for companion animal healthcare products, including vaccines, parasiticides, and nutritional supplements, is reshaping market dynamics, particularly in urban and developed regions

  • For instance, companies such as Zoetis, IDEXX, and Boehringer Ingelheim are expanding their portfolios with advanced diagnostics, vaccines, and digital health solutions to support preventive veterinary care

• Increased focus on data-driven herd management, wearable animal health monitoring devices, and precision livestock farming is accelerating adoption across both companion and production animal segments
• Overall, the integration of preventive care and digital health solutions is positioning animal healthcare as a technology-driven, outcome-focused industry with long-term growth potential

What are the Key Drivers of Animal Healthcare Market?

• Rising global pet adoption, increasing expenditure on veterinary care, and growing emotional attachment to companion animals are key drivers supporting market expansion

  • For instance, during 2024–2025, leading players such as Elanco, Virbac, and Dechra Pharmaceuticals launched new vaccines, parasiticides, and therapeutic products to address evolving animal health needs

• Growing prevalence of zoonotic diseases, livestock infections, and food safety concerns is driving demand for vaccines, diagnostics, and feed additives across production animal segments
• Advancements in veterinary pharmaceuticals, biologics, and diagnostic technologies have improved treatment efficacy and disease management capabilities
• Increasing investments in veterinary infrastructure, animal nutrition, and herd health management are boosting adoption across emerging and developed markets
• Supported by regulatory initiatives, rising awareness, and continuous R&D investments, the animal healthcare market is expected to witness sustained long-term growth

Which Factor is Challenging the Growth of the Animal Healthcare Market?

• High costs of advanced veterinary treatments, diagnostics, and biologics remain a major challenge, particularly in developing economies and price-sensitive livestock markets

  • For instance, rising costs of biopharmaceutical manufacturing, cold-chain logistics, and regulatory compliance during 2024–2025 increased pricing pressure for several global animal health companies

• Limited access to veterinary professionals and healthcare infrastructure in rural and remote regions restricts timely diagnosis and treatment
• Stringent regulatory approval processes for animal drugs and vaccines increase development timelines and compliance costs
• Growing concerns related to antimicrobial resistance (AMR) are leading to tighter regulations on antibiotic usage, impacting traditional treatment approaches
• To overcome these challenges, companies are focusing on cost-effective formulations, preventive care solutions, digital veterinary platforms, and sustainable animal health practices to expand market reach

How is the Animal Healthcare Market Segmented?

The market is segmented on the basis of animal type, product type, distribution channel, and end use.

• By Animal Type

On the basis of animal type, the animal healthcare market is segmented into Production Animal and Companion Animal. The production animal segment dominated the market in 2025, accounting for around 55.6% of the total revenue share, driven by large-scale demand from livestock farming, poultry, dairy, and aquaculture industries. High consumption of vaccines, feed additives, antiparasitics, and therapeutics to prevent disease outbreaks and ensure food safety strongly supports this segment. Increasing global demand for meat, milk, and eggs, along with government initiatives to control zoonotic diseases, further reinforces dominance.

The companion animal segment is expected to witness the fastest growth during the forecast period, fueled by rising pet ownership, humanization of pets, and higher spending on veterinary care. Growing adoption of preventive care, diagnostics, specialty drugs, and pet insurance is accelerating demand, particularly in urban and developed regions.

• By Product Type

Based on product type, the animal healthcare market is segmented into Pharmaceuticals, Medical Devices, Veterinary Services, and Others. The pharmaceuticals segment dominated the market in 2025, holding approximately 48.9% of the market share, due to widespread use of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs across both companion and production animals. Continuous product launches, strong R&D investments, and rising disease prevalence support sustained demand for animal pharmaceuticals.

The medical devices segment is projected to grow at the fastest CAGR, driven by increasing adoption of diagnostic imaging systems, monitoring devices, surgical instruments, and wearable health trackers. Advancements in veterinary diagnostics, rising demand for early disease detection, and growing use of point-of-care devices are accelerating adoption, particularly in companion animal care and advanced veterinary clinics.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into Retail, E-commerce, Hospital Pharmacy, and Others. The hospital pharmacy segment dominated the market in 2025, accounting for over 42.3% of total revenue, as veterinary hospitals and clinics remain the primary point of purchase for prescription drugs, vaccines, and diagnostic products. Direct access to veterinarians and assured product authenticity continue to support strong demand through this channel.

The e-commerce segment is expected to grow at the fastest rate, supported by increasing digitalization, convenience of home delivery, and rising penetration of online pet care platforms. Growing acceptance of online pharmacies, subscription-based pet medication services, and expanding internet access in emerging markets are significantly boosting adoption of e-commerce channels.

• By End Use

By end use, the animal healthcare market is segmented into Reference Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals and Clinics, and Others. The veterinary hospitals and clinics segment dominated the market in 2025, with a market share of nearly 50.1%, driven by high patient inflow, availability of skilled veterinarians, and comprehensive diagnostic and treatment capabilities. These facilities serve as central hubs for vaccinations, diagnostics, surgeries, and long-term animal care.

The point-of-care testing/in-house testing segment is anticipated to witness the fastest growth, owing to increasing demand for rapid diagnostics, immediate treatment decisions, and cost-efficient testing solutions. Technological advancements in portable diagnostic devices and rising focus on early disease detection are accelerating adoption across clinics, farms, and mobile veterinary services.

Which Region Holds the Largest Share of the Animal Healthcare Market?

• North America dominated the animal healthcare market with a 32.25% revenue share in 2025, driven by high pet ownership rates, advanced veterinary infrastructure, and strong spending on companion animal care across the U.S. and Canada. Widespread adoption of preventive healthcare, diagnostics, vaccines, and specialty pharmaceuticals continues to fuel market growth across veterinary hospitals, clinics, and reference laboratories
• Leading animal health companies in North America are actively launching innovative vaccines, parasiticides, biologics, and digital diagnostic solutions, strengthening the region’s technological and commercial leadership. Continuous investment in veterinary R&D, pet insurance expansion, and precision livestock management supports long-term market expansion
• High awareness of animal welfare, strong regulatory frameworks, and a well-established veterinary workforce further reinforce North America’s dominance in the global animal healthcare market

U.S. Animal Healthcare Market Insight

The U.S. is the largest contributor within North America, supported by strong demand for companion animal pharmaceuticals, diagnostics, and advanced veterinary services. Rising pet humanization, increasing veterinary visits, and high adoption of preventive care products such as vaccines and parasiticides continue to drive market growth. Presence of major animal health companies, robust veterinary infrastructure, and extensive R&D activity further strengthen the U.S. market.

Canada Animal Healthcare Market Insight

Canada contributes significantly to regional growth, driven by increasing pet ownership, rising livestock health management needs, and growing adoption of diagnostic and preventive veterinary solutions. Government-supported animal health programs, strong food safety regulations, and expanding veterinary service networks support steady market development across the country.

Asia-Pacific Animal Healthcare Market

Asia-Pacific is projected to register the fastest CAGR of around 8.69% from 2026 to 2033, driven by rapid growth in livestock production, rising pet adoption, and increasing awareness of animal health across China, India, Japan, South Korea, and Southeast Asia. Expanding middle-class populations, urbanization, and improving access to veterinary services are accelerating demand for animal healthcare products and services.

China Animal Healthcare Market Insight

China is the largest contributor within Asia-Pacific due to its vast livestock population, growing companion animal base, and increasing government focus on disease prevention and food safety. Rising adoption of vaccines, feed additives, and veterinary pharmaceuticals, along with expanding domestic manufacturing, continues to drive market growth.

Japan Animal Healthcare Market Insight

Japan shows steady growth supported by high pet ownership, strong emphasis on companion animal wellness, and advanced veterinary diagnostics adoption. Increasing demand for premium veterinary services, specialty drugs, and preventive care solutions reinforces long-term market expansion.

India Animal Healthcare Market Insight

India is emerging as a high-growth market, driven by expanding livestock farming, rising pet adoption in urban areas, and increasing awareness of animal health management. Government vaccination programs, growth of domestic animal health companies, and improving veterinary infrastructure are accelerating market penetration.

South Korea Animal Healthcare Market Insight

South Korea contributes to regional growth through rising companion animal ownership, increasing veterinary expenditure, and growing adoption of advanced diagnostics and specialty therapeutics. Strong focus on animal welfare and expanding pet healthcare services supports sustained market development.

Which are the Top Companies in Animal Healthcare Market?

The animal healthcare industry is primarily led by well-established companies, including:

• Zoetis (U.S.)
• Boehringer Ingelheim International GmbH (Germany)
• Bayer AG (Germany)
• Elanco (U.S.)
• Virbac (France)
• Intervet Inc. (U.S.)
• Ceva (France)
• Vetoquinol S.A. (France)
• Covetrus (U.S.)
• IDEXX (U.S.)
• Nutreco (Netherlands)
• Intas Pharmaceuticals Ltd. (India)
• Zydus Animal Health and Investments Limited (India)
• Eli Lilly and Company (U.S.)
• Hester Biosciences Limited (India)
• Alivira Animal Health Limited (India)
• Norbrook (U.K.)
• Phibro Animal Health Corporation (U.S.)
• Dechra Pharmaceuticals PLC (U.K.)

What are the Recent Developments in Global Animal Healthcare Market?

• In October 2024, VMD Sciences introduced Expanded Access Programs (EAPs) for pets and livestock, enabling veterinarians to safely access innovative, potentially life-saving therapies not widely available through conventional channels, thereby helping address critical unmet needs in veterinary medicine and strengthening advanced treatment adoption
• In May 2024, the USDA’s Animal and Plant Health Inspection Service (APHIS) allocated over USD 22.2 million to enhance early disease detection, preparedness, prevention, and rapid response for major livestock diseases in the U.S., reinforcing national animal health security and supporting long-term livestock resilience
• In November 2023, Bimeda inaugurated a new manufacturing facility in China focused on sterile injections and parasite-control products, expanding its global production capacity and improving supply availability across key animal healthcare markets
• In October 2023, Zoetis commercially launched Librela, its anti-NGF monoclonal antibody therapy for canine osteoarthritis pain in the U.S., marking a significant advancement in companion animal pain management and strengthening its leadership in innovative veterinary therapeutics

SKU-64308